RGLS regulusrx.com: Nilai bisnis marang pendapatan

Logo perusahaan publik Regulus Therapeutics, Inc. (RGLS)

Regulus Therapeutics (RGLS) develops miRNA-based drugs to treat polycystic kidney disease, leveraging unique patents to drive future FCF growth. However, success depends on regulatory approvals and the volume of R&D reserves. The current EV/Sales ratio reflects market expectations, where the value of characterizes this level. Since there are no commercial products, the company remains in a phase of pure capital consumption without operational inertia.

RGLS Rasio nilai perusahaan marang pendapatan Regulus Therapeutics, Inc. (04.07.2022 - 19.11.2026)

Rincian metrik keuangan lan pasar Regulus Therapeutics, Inc. (RGLS)

- rega lan prakiraan konsensus rega:
Pambiji fundamental:Regulus Therapeutics (RGLS)
Barang utama Regulus Therapeutics Inc.

This indicator compares the total enterprise value with the volume of generated sales, excluding the impact of debt load to identify the real market valuation of assets. The integration of green chemistry principles into the RNA therapeutics of Regulus Therapeutics (RGLS) affects operating expenses, which is reflected in the EV/Sales multiple trend, allowing investors to judge the capitalization efficiency of environmental initiatives and overall capital sustainability.

Analisis pesaing Regulus Therapeutics

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Multiplikator EV/Sales|GBIO - Multiplikator EV/Sales|BOLD: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XCUR|Rasio nilai perusahaan marang pendapatan Imunon|Phio Pharmaceuticals - Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Mustang Bio, Inc. (MBIO)|Rasio total nilai perusahaan marang pendapatan TransCode Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan Bionano Genomics BNGO|Nilai bisnis marang pendapatan APDN|BLUE - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan IPA|Omega Therapeutics, Inc. (OMGA) - Rasio nilai perusahaan marang pendapatan|Singular Genomics Corp (OMIC) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan